CIBC World Market
IBB icon

CIBC World Market’s iShares Biotechnology ETF IBB Stock Holding History

CIBC World Market’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
6,666
+789
+13% +$136K ﹤0.01% 965
2026
Q1 		$992K Buy
5,877
+499
+9% +$85.3K ﹤0.01% 940
2025
Q4 		$908K Buy
5,378
+1,391
+35% +$226K ﹤0.01% 968
2025
Q3 		$576K Buy
3,987
+526
+15% +$71.8K ﹤0.01% 1075
2025
Q2 		$438K Buy
3,461
+164
+5% +$20.1K ﹤0.01% 1089
2025
Q1 		$422K Sell
3,297
-757
-19% -$103K ﹤0.01% 1077
2024
Q4 		$536K Buy
4,054
+36
+0.9% +$5.06K ﹤0.01% 1025
2024
Q3 		$585K Sell
4,018
-601
-13% -$87K ﹤0.01% 951
2024
Q2 		$634K Buy
4,619
+418
+10% +$55.8K ﹤0.01% 902
2024
Q1 		$576K Buy
4,201
+901
+27% +$123K ﹤0.01% 949
2023
Q4 		$448K Buy
3,300
+48
+1% +$5.86K ﹤0.01% 961
2023
Q3 		$398K Sell
3,252
-177
-5% -$22.5K ﹤0.01% 963
2023
Q2 		$435K Sell
3,429
-246
-7% -$32K ﹤0.01% 960
2023
Q1 		$475K Sell
3,675
-5,854
-61% -$766K ﹤0.01% 938
2022
Q4 		$1.25M Buy
9,529
+3,591
+60% +$464K ﹤0.01% 711
2022
Q3 		$695K Sell
5,938
-1,342
-18% -$167K ﹤0.01% 810
2022
Q2 		$856K Sell
7,280
-951
-12% -$113K ﹤0.01% 759
2022
Q1 		$1.07M Sell
8,231
-717
-8% -$93.4K ﹤0.01% 726
2021
Q4 		$1.37M Buy
8,948
+819
+10% +$127K ﹤0.01% 705
2021
Q3 		$1.31M Sell
8,129
-22,587
-74% -$3.8M ﹤0.01% 710
2021
Q2 		$5.03M Buy
30,716
+23,130
+305% +$3.56M 0.01% 370
2021
Q1 		$1.14M Sell
7,586
-1,280
-14% -$203K ﹤0.01% 740
2020
Q4 		$1.34M Sell
8,866
-635
-7% -$90.8K ﹤0.01% 664
2020
Q3 		$1.29M Sell
9,501
-6,457
-40% -$876K 0.01% 598
2020
Q2 		$2.18M Buy
15,958
+7,979
+100% +$1.02M 0.01% 462
2020
Q1 		$860K Buy
7,979
+2,426
+44% +$279K ﹤0.01% 577
2019
Q4 		$669K Sell
5,553
-4,879
-47% -$544K ﹤0.01% 745
2019
Q3 		$1.04M Sell
10,432
-17,459
-63% -$1.83M ﹤0.01% 619
2019
Q2 		$3.04M Sell
27,891
-355
-1% -$37.8K 0.01% 393
2019
Q1 		$3.16M Sell
28,246
-3,517
-11% -$386K 0.01% 391
2018
Q4 		$3.06M Buy
31,763
+948
+3% +$101K 0.02% 342
2018
Q3 		$3.76M Sell
30,815
-11,567
-27% -$1.36M 0.02% 352
2018
Q2 		$4.65M Buy
42,382
+5,154
+14% +$551K 0.02% 299
2018
Q1 		$3.97M Buy
37,228
+30,421
+447% +$3.37M 0.02% 327
2017
Q4 		$727K Sell
6,807
-2,340
-26% -$250K ﹤0.01% 481
2017
Q3 		$1.02M Sell
9,147
-12,600
-58% -$1.35M ﹤0.01% 394
2017
Q2 		$2.25M Buy
21,747
+12,159
+127% +$1.2M 0.01% 440
2017
Q1 		$937K Sell
9,588
-3,726
-28% -$357K ﹤0.01% 596
2016
Q4 		$1.18M Buy
13,314
+10,908
+453% +$993K ﹤0.01% 581
2016
Q3 		$232K Sell
2,406
-285
-11% -$27.1K ﹤0.01% 892
2016
Q2 		$231K Buy
2,691
+117
+5% +$10.5K ﹤0.01% 832
2016
Q1 		$224K Sell
2,574
-789
-23% -$70.6K ﹤0.01% 784
2015
Q4 		$379K Sell
3,363
-1,458
-30% -$158K ﹤0.01% 697
2015
Q3 		$487K Sell
4,821
-14,376
-75% -$1.72M ﹤0.01% 614
2015
Q2 		$2.36M Buy
19,197
+423
+2% +$50.6K 0.01% 308
2015
Q1 		$2.15M Buy
18,774
+13,404
+250% +$1.48M 0.01% 282
2014
Q4 		$543K Buy
+5,370
New +$522K ﹤0.01% 588

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

CIBC World Market's IBB Position: Q2 2026 in Review

CIBC World Market increased its iShares Biotechnology ETF (IBB) stake by 13% in Q2 2026, buying an estimated $136K and bringing the position to 6,666 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #965.

CIBC World Market first reported a position in IBB in Q4 2014 and has held it in 47 quarters since. The position peaked at $5.03M in Q2 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • CIBC World Market held 6,666 shares of iShares Biotechnology ETF worth $1.27M as of Q2 2026.
  • CIBC World Market bought 789 iShares Biotechnology ETF shares in Q2 2026, an estimated $136K.
  • iShares Biotechnology ETF made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #965 holding.
  • CIBC World Market first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 47 quarters since.
  • CIBC World Market's iShares Biotechnology ETF position peaked at $5.03M in Q2 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.